Marker Therapeutics, Inc. (MRKR)
NASDAQ: MRKR · Real-Time Price · USD
1.470
+0.090 (6.52%)
At close: Mar 9, 2026, 4:00 PM EDT
1.450
-0.020 (-1.36%)
After-hours: Mar 9, 2026, 6:24 PM EDT

Marker Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
253349237970
Upgrade
Market Cap Growth
71.33%-31.89%115.29%-71.23%13.36%-47.12%
Upgrade
Enterprise Value
82431124255
Upgrade
Last Close Price
1.383.115.502.669.5014.50
Upgrade
PS Ratio
5.345.0514.776.4663.58149.18
Upgrade
PB Ratio
1.251.793.481.161.802.55
Upgrade
P/TBV Ratio
1.361.793.481.161.802.55
Upgrade
EV/Sales Ratio
1.603.699.493.5234.02117.63
Upgrade
Debt / Equity Ratio
----0.270.45
Upgrade
Net Debt / Equity Ratio
-0.96-1.03-1.07-0.60-0.69-0.33
Upgrade
Net Debt / EBITDA Ratio
--1.280.690.820.32
Upgrade
Net Debt / FCF Ratio
1.191.760.920.441.000.31
Upgrade
Asset Turnover
0.290.340.130.070.020.01
Upgrade
Quick Ratio
5.766.225.251.823.283.49
Upgrade
Current Ratio
6.506.365.572.143.563.81
Upgrade
Return on Equity (ROE)
-110.67%-65.81%-83.47%-62.20%-117.42%-80.37%
Upgrade
Return on Assets (ROA)
-55.20%-35.50%-35.36%-24.12%-43.38%-39.26%
Upgrade
Return on Capital Employed (ROCE)
-78.40%-59.90%-103.80%-74.30%-71.50%-73.70%
Upgrade
Earnings Yield
-56.98%-32.23%-16.85%-131.80%-53.05%-41.22%
Upgrade
FCF Yield
-59.05%-32.76%-33.63%-118.78%-38.52%-42.06%
Upgrade
Buyback Yield / Dilution
-43.29%-1.94%-5.49%-9.16%-62.64%-3.19%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.